Home
  • About Seera
    • Overview
    • Chairman’s Message
    • Directors & Shari’a Board
    • Our Team
    • Financial Information
    • Financial Results
    • Annual Reports
  • Our Business
    • Our Business Strategy
    • Investment Process
    • Investment Portfolio
  • Corporate Governance
    • Overview
    • Shareholders
    • Shari’a Compliance
    • Compliance
    • Risk Management
    • Code of Conduct
  • Media & Communications
    • News
    • White Papers
  • Contact us

Latest News

05-April-2016 Pregabalin 150 mg purchase Seera Reports $2.8 Million Net Profit for 2015 where to purchase antabuse Read More
03-September-2015
Seera Successfully Completes Sale of Kosan Crisplant for DKK 424 million
Read More

31-August-2015
Seera Reports $2.3 Million Net Profit for First Half of 2015
Read More

Sitemap

Sitemap

  • Pages
    • test
    • Terms of Use
    • Contact us
    • Media & Communications
      • White Papers
      • News
    • Corporate Governance
      • Code of Conduct
      • Risk Management
      • Compliance
      • Shari’a Compliance
      • Shareholders
      • Overview
    • Our Business
      • BWA Water Additives
      • Investment Portfolio
      • Investment Process
      • Our Business Strategy
    • About Seera
      • Annual Reports
      • Financial Results
      • Financial Information
      • Our Team
      • Directors & Shari’a Board
      • Chairman’s Message
      • Overview
    • Focused on the Future
Privacy Notice | Terms of Use | Site Map | Seera Investment Company B.S.C.(c) 2018